Johnson & Johnson is going full throttle on twin fronts in hopes of getting a COVID-19 vaccine on the market by early next year. It has ramped up research and development processes to "unprecedented levels" and is expanding its global manufacturing capacity to be able to produce one billion doses of the vaccine.
The company announced on 30 March that it had selected a lead COVID-19 vaccine candidate from constructs it began working...







